Search tool

General population survey data from EU Member States show that cannabis is the illicit drug most used by Europeans. The latest data show that an estimated 14.6 million young Europeans (aged 15–34)...

Comparable and reliable information on the numbers and characteristics of those entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting...

Drug strategies and plans adopted over the last five years by six intergovernmental organisations engage 148 countries in five continents. Here, we present a brief overview of these documents, looking at their...

This report provides an update on infectious diseases related to injecting drug use in Europe for the period up to June 2015. The report covers both the EMCDDA Drug-related infectious diseases indicator...

This publication is an update of Prevention of substance abuse, published in 2007. Like the previous analysis, it is a translation of a German study that presents a state-of-the-art review of prevention...

In this issue: New technical report on estimating trends in injecting drug use | EMCDDA: 20 years of monitoring | Memorandum of Understanding with Armenia | EMCDDA launches IPA 5 project with...

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...

This report presents the key activities performed by the EMCDDA and Europol in 2014, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the...

This short report provides an overview of how European countries are developing innovative legal responses to the challenges presented to public health and drug policy by the rapidly evolving market for new...